Excerpt from Atopic DermatitisSynonyms, Key Words, and Related Terms: infantile eczema, Besnier's prurigo, intrinsic eczema, extrinsic eczema, atopiform eczema, asthma, food allergy, peanut allergy, allergic reaction Please click here to view the full topic text: Atopic DermatitisBackgroundAtopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy and is typified by pruritus, eczematous lesions, xerosis (dry skin), and lichenification on the skin (thickening of the skin and increase in skin markings). AD is associated with other atopic diseases (eg, asthma, allergic rhinitis, urticaria, acute allergic reactions to foods, increased immunoglobulin E [IgE] production) in many patients. It is a disease of great morbidity, and the incidence appears to be increasing. PathophysiologyThe pathophysiology of AD is poorly understood. Several cell types seem to be involved, including T lymphocytes, eosinophils, Langerhans cells, and keratinocytes. Other factors, including cytokines and IgE, are also implicated. Laboratory findings suggest a number of different pathogenetic mechanisms. One invokes an immune defect involving an abnormality of TH2 cells that interacts with Langerhans cells and results in increased production of interleukin (IL)–4, IL-5, IL-6, IL-10, and IL-13. This leads to increased IgE and decreased gamma interferon levels. The imbalance of TH2 cells occurs in the acute process, with a swing toward TH1 cells in the chronic stages of the disease. Another theory involves defective barrier function in the stratum corneum leading to the entry of antigens, which results in the production of various inflammatory cytokines. Xerosis is known to be an associated sign in most AD patients. The xerosis is thought to involve defective lipid (particularly ceramide) production. A third mechanism involves environmental antigens from food (the gut), dust mites (the lungs), and other factors and portals of entry that react with antibodies to produce increased levels of IgE and, possibly, increased histamine reactions from mast dells. Superimposed with these mechanisms is a genetic predisposition to react to various environmental allergens. FrequencyUnited StatesThe prevalence rate is 10-12% in children and 0.9% in adults. InternationalThe prevalence rate is as high as 18% and is rising, especially in developed countries. In China and Iran, the prevalence rate is approximately 2-3%. The frequency is increased in patients who immigrate to developed countries from underdeveloped countries. Mortality/MorbidityIncessant itch and work loss in adult life is a great financial burden. A number of studies have reported that the financial burden to families and government is similar to that of asthma, arthritis, and diabetes mellitus. In children, the disease causes enormous psychological burden to families and loss of school days. Mortality due to AD is unusual.
RaceAD may be more common among whites, but it affects persons of all races. SexThe male-to-female ratio is 1:1.4. AgeIn 85% of cases, AD occurs in the first year of life; in 95% of cases, it occurs before age 5 years.
Please click here to view the full topic text: Atopic Dermatitis |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |